Skip to content

Effective Treatments for Thoracic Aortic Aneurysms (ETTAA Study): A Prospective Cohort Study

Effective Treatments for Thoracic Aortic Aneurysms (ETTAA Study): A Prospective Cohort Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02010892
Acronym
ETTAA
Enrollment
2200
Registered
2013-12-13
Start date
2014-02-28
Completion date
2019-07-31
Last updated
2016-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic Aortic Aneurysm

Brief summary

This is a prospective observational cohort study that will collect data from the point of referral through to secondary care, aiming for 3 years median follow-up (range 1-5 years). The data collected will allow estimation of the success of any intervention (in terms of reducing rate of aneurysm growth, rupture or dissection) as well as estimation of the risks associated with the three procedures. Clinical outcomes in the three treatment groups will be described. Aims We aim to answer the following questions: 1. Without procedural intervention for chronic thoracic aortic aneurysm (CTAA), what is the risk of aneurysm growth, dissection, rupture, permanent neurological injury or death? What is the effect on quality of life (QoL)? 2. If a patient has endovascular stent grafting (ESG) or open surgical repair (OSR), what is the risk of growth, dissection, rupture, permanent neurological injury or death? 3. How does QoL change from pre- to post intervention? 4. Can aneurysm or patient related predictors of good/poor treatment outcomes be determined? 5. What is the most cost-effective strategy in: 1. Patients eligible for either ESG or OSR? 2. Patients eligible for either ESG or best medical therapy (BMT)? 3. Patients eligible for either watchful waiting (WW) or intervention (ESG/ OSR)? 6. What further research is required? What would be the most important research to pursue?

Interventions

PROCEDUREStent Grafting (ESR)
PROCEDUREOpen Surgery (OSR)

Sponsors

Papworth Hospital NHS Foundation Trust
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Thoracic Aortic Aneurysm \> 4cm * Age ≥18 years * Able to give informed consent

Exclusion criteria

* Intervention required below the level of the coeliac axis * Acute dissection or malperfusion syndromes (such as myocardial infarction,acute stroke or limb ischaemia)

Design outcomes

Primary

MeasureTime frame
Aneurysm Growth1, 2, 3 , 4 and 5 years post recruitment
Quality of life1, 2, 3 , 4 and 5 years post recruitment
Freedom from reintervention1, 2, 3 , 4 and 5 years post recruitment
Freedom from death or permanent neurological injury1, 2, 3 , 4 and 5 years post recruitment
Costs to the NHS1, 2, 3 , 4 and 5 years post recruitment
Incremental cost per quality adjusted life year gained1, 2, 3 , 4 and 5 years post recruitment

Countries

United Kingdom

Contacts

Primary ContactVikki Hughes, PhD
victoria.hughes@papworth.nhs.uk01480 364821

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026